Dengue: an update
- PMID: 11892494
- DOI: 10.1016/s1473-3099(01)00171-2
Dengue: an update
Abstract
This review is an update of dengue and dengue haemorrhagic fever (DHF) based on international and Cuban experience. We describe the virus characteristics and risk factors for dengue and DHF, and compare incidence and the case fatality rates in endemic regions (southeast Asia, western Pacific, and the Americas). The clinical picture and the pathogenesis of the severe disease are explained. We also discuss the viral, individual, and environmental factors that determine severe disease. Much more research is necessary to clarify these mechanisms. Also reviewed are methods for viral isolation and the serological, immunohistochemical, and molecular methods applied in the diagnosis of the disease. We describe the status of vaccine development and emphasise that the only alternative that we have today to control the disease is through control of its vector Aedes aegypti.
Comment in
-
Dengue in Cuba: mobilisation against Aedes aegypti.Lancet Infect Dis. 2002 Apr;2(4):207-8. doi: 10.1016/s1473-3099(02)00238-4. Lancet Infect Dis. 2002. PMID: 11937420 No abstract available.
Similar articles
-
Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?Lancet. 2000 May 27;355(9218):1902-3. doi: 10.1016/S0140-6736(00)02303-5. Lancet. 2000. PMID: 10866460
-
Epidemiologic studies on Dengue in Santiago de Cuba, 1997.Am J Epidemiol. 2000 Nov 1;152(9):793-9; discussion 804. doi: 10.1093/aje/152.9.793. Am J Epidemiol. 2000. PMID: 11085389
-
Invited commentary: Dengue lessons from Cuba.Am J Epidemiol. 2000 Nov 1;152(9):800-3. doi: 10.1093/aje/152.9.800. Am J Epidemiol. 2000. PMID: 11085390 Review.
-
Dengue in the Americas and Southeast Asia: do they differ?Rev Panam Salud Publica. 2006 Dec;20(6):407-15. doi: 10.1590/s1020-49892006001100007. Rev Panam Salud Publica. 2006. PMID: 17341332 Review.
-
Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges.J Clin Virol. 2003 May;27(1):1-13. doi: 10.1016/s1386-6532(03)00010-6. J Clin Virol. 2003. PMID: 12727523 Review.
Cited by
-
Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM.Appl Microbiol Biotechnol. 2015 Jul;99(14):5917-27. doi: 10.1007/s00253-015-6538-9. Epub 2015 Mar 31. Appl Microbiol Biotechnol. 2015. PMID: 25822571 Free PMC article.
-
Green synthesis of silver nanoparticles using Murraya koenigii leaf extract against Anopheles stephensi and Aedes aegypti.Parasitol Res. 2013 Apr;112(4):1385-97. doi: 10.1007/s00436-012-3269-z. Epub 2013 Jan 16. Parasitol Res. 2013. PMID: 23322327
-
Health beliefs and practices related to dengue fever: a focus group study.PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2310. doi: 10.1371/journal.pntd.0002310. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23875045 Free PMC article.
-
Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials.PLoS Negl Trop Dis. 2016 Jul 14;10(7):e0004821. doi: 10.1371/journal.pntd.0004821. eCollection 2016 Jul. PLoS Negl Trop Dis. 2016. PMID: 27414655 Free PMC article. Clinical Trial.
-
Dengue type 3 virus, Saint Martin, 2003-2004.Emerg Infect Dis. 2005 May;11(5):757-61. doi: 10.3201/eid1105.040959. Emerg Infect Dis. 2005. PMID: 15890134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical